Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02544009
Other study ID # 150192
Secondary ID 15-DK-0192
Status Completed
Phase
First received
Last updated
Start date September 5, 2015
Est. completion date May 19, 2016

Study information

Verified date May 9, 2024
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: Many people regain the weight they lose through diet and exercise. This might happen because the weight loss slows their metabolism. This slowing is called metabolic adaptation. It may cause people to regain weight if they do not keep up high levels of exercise or major caloric restrictions. Researchers want to find the long-term effects of metabolic adaptation in the previous Biggest Loser study participants. They hope to learn the body s response to lifestyle changes that result in weight loss. They also want to see if certain changes can lead to longer-term success in maintaining weight loss. Objectives: To better understand the long-term metabolic changes caused by rapid weight loss achieved through diet restriction and vigorous physical activity. Eligibility: Former Biggest Loser research study participants (Protocol No. PBRC29008). Design: Participants will be screened with a phone interview. This study has 3 phases. Phase 1 will last at least 3 weeks. Participants will receive a physical activity monitor and wireless scale. These will send their daily weight and activity back to NIH. In Phase 2, participants will stay at NIH for 3 days. Their metabolism will be measured through: Their activity monitor Urine samples and daily body weight Medical review and physical exam Fasting for 12 hours each night for a blood draw the following morning DEXA: a low-dose x-ray of the body BIS: Electrodes on the hand/wrist and foot/ankle measure body water content. Phase 3 will last at least 3 weeks. Participants will: Continue to monitor their daily weight and activity Collect urine samples and send them back to NIH


Description:

Weight loss is accompanied by a slowing of metabolic rate. Metabolic slowing often occurs to a degree greater than predicted by the amount of weight lost, a phenomenon called metabolic adaptation , and is hypothesized to persist over time and promote weight regain. We previously discovered large metabolic adaptations in response to the intensive lifestyle intervention as part of The Biggest Loser weight loss competition. Those subjects rapidly lost massive amounts of weight and their resting energy expenditure decreased by ~500 kcal/d more than was expected based on their body composition at the end of the intervention. The purpose of this study is to investigate whether the metabolic adaptation has persisted in the years following the intervention in the same subjects. Furthermore, we will measure body weight and composition in these subjects and investigate the correlates of weight regain.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date May 19, 2016
Est. primary completion date May 19, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - INCLUSION CRITERIA: - 16 subjects who previously participated in the Biggest Loser study (Pennington Biomedical Research Center protocol no. PBRC29008). - Written informed consent EXCLUSION CRITERIA: - Volunteers unwilling or unable to give informed consent. - Women who are pregnant or breastfeeding cannot participate in the study. A pregnancy test will be performed during the first day of the inpatient visit. If the pregnancy test is positive, the subject cannot continue to participate in the study. - Subjects with implantable cardio-defibrillator or pacemaker may not participate in the bioelectric impedance spectroscopy (BIS) testing portion of the study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure body composition and REE several years after completion of The Biggest Loser intervention. Metabolic adaptation will be calculated as the difference between the measured REE and the REE predicted from linear regression analysis of baseli... The primary analysis will use a t-test to test the null hypothesis that this difference is equal to zero. Secondary analyses will explore predictors of metabolic adaptation. 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT05998096 - A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators N/A
Suspended NCT00823329 - Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status Phase 0
Completed NCT01317732 - MOTIONPOD (TM) Validation and Calibration Study N/A
Completed NCT00781586 - Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women. Phase 4
Completed NCT04389736 - Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion N/A
Completed NCT02272166 - Effects of Propofol on Early Recovery of Hunger After Surgery Phase 4
Completed NCT02790255 - BRown Fat Activity Measurement With Infrared imaginG tHermography andThermogenesis - the BRIGHT Study N/A
Completed NCT00995579 - Assessment of Energy Expenditure by Indirect Calorimetry for a Daily 10,000 Steps Goal N/A
Completed NCT03378115 - Energy Cost of Posture Maintenance, Ethnic Differences and the Influence of Metabolic State
Recruiting NCT06432517 - Sources and Mechanisms of Energy Compensation N/A
Not yet recruiting NCT06320951 - VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway Phase 2
Completed NCT05412511 - Metabolic Cost of Medicine Ball Training N/A
Completed NCT05412498 - Metabolic Cost of Battle Rope Training N/A
Recruiting NCT03101215 - Workload of Water Polo Players Following a Phosphorus Manipulated High Carbohydrate Meal N/A
Completed NCT02118662 - Energy Expenditure During Seated, Seated Cycling, and Treadmill Walking Work Conditions (EE-Work) N/A
Completed NCT03602144 - Breakfast and Muscle Health in Children N/A
Completed NCT01029236 - Evaluation of Metabolism-Boosting Beverages N/A
Terminated NCT00586807 - Metabolic Response to Infliximab in Pediatric Ulcerative Colitis N/A
Completed NCT04818905 - Helichrysum Italicum Infusion Ingestion in Humans N/A
Completed NCT03603041 - Nutrition, Body Composition, and Sleep N/A